Bookedited by M.A. Hayat.
Contents:
1. Introduction
2. The management and biology of metastatic cancers to the brain
3. Melanoma metastases are underrepresented in cerebellum compared with metastases from colorectal cancers
4. Risk reductions of recurrence and mortality in melanoma patients using IFN-α
5. Brain metastases from melanoma
6. Pathobiology of brain metastases: molecular mechanisms
7. Role of CDKN₂A mutations and other relevant genes in melanoma predisposition
8. The role of the receptor for advanced glycation end products in malignant melanoma
9. Hydrogen sulfide pathway and cancer
10. Brain metastasis from esophageal cancer
11. Treatment of metastatic melanoma patients bearing c-kit mutation using imatinib mesylate
12. Optimal selection of targeted therapies for melanoma patients: role of the mitogen-activated protein kinase pathway
13. Patients with brain metastases from melanoma: treatment with surgery and radiotherapy
14. The risks and advantages of whole brain radiation therapy in patients with brain metastases
15. Gastrointestinal stromal tumors with intracranial metastasis: treatment strategy and review of the literature
16. Brain metastases from breast cancer in patients receiving trastuzumab
17. Brain metastases from cutaneous melanoma: biology and its implications for more rational therapeutic approaches
18. Treatment of brain metastases from ovarian and endometrial carcinomas using stereotactic radiosurgery
19. Prognostic factors for survival in melanoma patients with brain metastases
20. Management of melanoma therapy-associated toxicities
21. Brain metastases from breast cancer: focus on risk factors, treatment, and clinical outcome.